<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05907572580495</udiDi>
    <basicUdiDi>803413527TD067STNCPHTHLSC</basicUdiDi>
    <tradeName>Hialag</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO066</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-08T08:27:37.487Z</lastUpdated>
  </row>
  <row>
    <udiDi>05907572580600</udiDi>
    <basicUdiDi>803413527TD066HYPRTNCPHU7</basicUdiDi>
    <tradeName>Cornesin Masc</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO070</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-08T08:27:37.456Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135271839</udiDi>
    <basicUdiDi>803413527TD029PHTHLMCSLJB</basicUdiDi>
    <tradeName>Droptiva Plus</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CMC043</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:26:47.571Z</lastUpdated>
  </row>
  <row>
    <udiDi>05213010813453</udiDi>
    <basicUdiDi>803413527THENOPHTHLMCGLST</basicUdiDi>
    <tradeName>Helenvision Balance</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DEX042</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:18:46.870Z</lastUpdated>
  </row>
  <row>
    <udiDi>05212001113893</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>HYAL 0.2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS222</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:18:46.059Z</lastUpdated>
  </row>
  <row>
    <udiDi>03857500055330</udiDi>
    <basicUdiDi>803413527TD072SLTNFRCLRNJ</basicUdiDi>
    <tradeName>Proluxx Duo</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PES061</reference>
    <placedOnMarketCountry>Slovenia</placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:18:38.055Z</lastUpdated>
  </row>
  <row>
    <udiDi>03857500055392</udiDi>
    <basicUdiDi>803413527TD066HYPRTNCPHU7</basicUdiDi>
    <tradeName>Proluxx Edenight</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO071</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:18:36.465Z</lastUpdated>
  </row>
  <row>
    <udiDi>03857500055347</udiDi>
    <basicUdiDi>803413527TD067STNCPHTHLSC</basicUdiDi>
    <tradeName>Proluxx Night</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO058</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T05:18:35.665Z</lastUpdated>
  </row>
  <row>
    <udiDi>08470001772107</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Solucion oftalmica hidratante HA 0.2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS220</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T23:40:22.994Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135272355</udiDi>
    <basicUdiDi>803413527TD067STNCPHTHLSC</basicUdiDi>
    <tradeName>Puro Protect</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO061</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T10:05:23.042Z</lastUpdated>
  </row>
  <row>
    <udiDi>05212001102163</udiDi>
    <basicUdiDi>803413527TD066HYPRTNCPHU7</basicUdiDi>
    <tradeName>Edenight</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO057</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-20T21:24:37.509Z</lastUpdated>
  </row>
  <row>
    <udiDi>05212001123892</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Hyal plus 0.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS225</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-20T21:24:37.458Z</lastUpdated>
  </row>
  <row>
    <udiDi>05213010813477</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Helenvision Max</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS235</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-20T21:24:10.207Z</lastUpdated>
  </row>
  <row>
    <udiDi>05213010813484</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Helenvision Pure</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS277</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-06-20T21:24:10.187Z</lastUpdated>
  </row>
  <row>
    <udiDi>08029408160699</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Ceramol ofta repair</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS312</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:10:23.419Z</lastUpdated>
  </row>
  <row>
    <udiDi>08029408183162</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Ceramol ofta repair</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS313</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:10:23.400Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135270740</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Hialeye free 0.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS224</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:35.797Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135271921</udiDi>
    <basicUdiDi>803413527TD050PHTHLMCSLD3</basicUdiDi>
    <tradeName>Hialeye free 0.2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HYS219</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:35.772Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135272294</udiDi>
    <basicUdiDi>803413527THENOPHTHLMCGLST</basicUdiDi>
    <tradeName>Puro Epithel</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DEX046</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:35.762Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135272812</udiDi>
    <basicUdiDi>803413527TD066HYPRTNCPHU7</basicUdiDi>
    <tradeName>Edenight</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO068</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:35.737Z</lastUpdated>
  </row>
</eudamedExport>